These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 10383458)
1. Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice. Wetsel RA; Kildsgaard J; Zsigmond E; Liao W; Chan L J Biol Chem; 1999 Jul; 274(27):19429-33. PubMed ID: 10383458 [TBL] [Abstract][Full Text] [Related]
2. Further insights into the pathophysiology of hyperapobetalipoproteinemia: role of basic proteins I, II, III. Kwiterovich PO; Motevalli M; Miller M; Bachorik PS; Kafonek SD; Chatterjee S; Beaty T; Virgil D Clin Chem; 1991 Mar; 37(3):317-26. PubMed ID: 2004437 [TBL] [Abstract][Full Text] [Related]
3. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia. Kildsgaard J; Zsigmond E; Chan L; Wetsel RA Mol Immunol; 1999; 36(13-14):869-76. PubMed ID: 10698341 [TBL] [Abstract][Full Text] [Related]
5. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein. Cianflone KM; Maslowska MH; Sniderman AD J Clin Invest; 1990 Mar; 85(3):722-30. PubMed ID: 2312723 [TBL] [Abstract][Full Text] [Related]
6. Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB. Zhang XJ; Cianflone K; Genest J; Sniderman AD Eur J Clin Invest; 1998 Sep; 28(9):730-9. PubMed ID: 9767372 [TBL] [Abstract][Full Text] [Related]
7. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Meijssen S; van Dijk H; Verseyden C; Erkelens DW; Cabezas MC Arterioscler Thromb Vasc Biol; 2002 May; 22(5):811-6. PubMed ID: 12006395 [TBL] [Abstract][Full Text] [Related]
8. Of mice and men (and women) and the acylation-stimulating protein pathway. Sniderman AD; Maslowska M; Cianflone K Curr Opin Lipidol; 2000 Jun; 11(3):291-6. PubMed ID: 10882345 [TBL] [Abstract][Full Text] [Related]
9. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Paglialunga S; Fisette A; Yan Y; Deshaies Y; Brouillette JF; Pekna M; Cianflone K Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E521-9. PubMed ID: 18160458 [TBL] [Abstract][Full Text] [Related]
10. [Adipsin system--acylation-stimulation protein (ASP) and hyperapo-B]. Rato Q; Cianflone K; Sniderman A Rev Port Cardiol; 1996 May; 15(5):433-8, 366. PubMed ID: 8763517 [TBL] [Abstract][Full Text] [Related]
11. Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice. Xia Z; Stanhope KL; Digitale E; Simion OM; Chen L; Havel P; Cianflone K J Biol Chem; 2004 Feb; 279(6):4051-7. PubMed ID: 14615480 [TBL] [Abstract][Full Text] [Related]
12. Response of plasma ASP to a prolonged fast. Cianflone K; Kalant D; Marliss EB; Gougeon R; Sniderman AD Int J Obes Relat Metab Disord; 1995 Sep; 19(9):604-9. PubMed ID: 8574269 [TBL] [Abstract][Full Text] [Related]
13. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Murray I; Havel PJ; Sniderman AD; Cianflone K Endocrinology; 2000 Mar; 141(3):1041-9. PubMed ID: 10698180 [TBL] [Abstract][Full Text] [Related]
14. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice. Murray I; Sniderman AD; Cianflone K Am J Physiol; 1999 Sep; 277(3):E474-80. PubMed ID: 10484359 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease. Kwiterovich PO; Coresh J; Bachorik PS Am J Cardiol; 1993 Mar; 71(8):631-9. PubMed ID: 8447257 [TBL] [Abstract][Full Text] [Related]
16. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Cianflone K; Maslowska M; Sniderman AD Semin Cell Dev Biol; 1999 Feb; 10(1):31-41. PubMed ID: 10355026 [TBL] [Abstract][Full Text] [Related]
17. HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. Kwiterovich PO Clin Chem; 1988; 34(8B):B71-7. PubMed ID: 3042202 [TBL] [Abstract][Full Text] [Related]
18. Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians. Weyer C; Pratley RE Obes Res; 1999 Sep; 7(5):444-52. PubMed ID: 10509601 [TBL] [Abstract][Full Text] [Related]
19. Etiologic heterogeneity of hyperapobetalipoproteinemia (hyperapoB). Results from segregation analysis in families with premature coronary artery disease. Juo SH; Beaty TH; Kwiterovich PO Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2729-36. PubMed ID: 9409249 [TBL] [Abstract][Full Text] [Related]
20. The relation between triglyceride synthesis in peripheral tissues and postprandial plasma triglyceride levels: preliminary evidence of a role for acylation stimulating protein. Cianflone KM; Sniderman AD; Dallongeville J; Bertrand M; Raffaï E; Davignon J Clin Invest Med; 1992 Apr; 15(2):132-40. PubMed ID: 1591895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]